439 related articles for article (PubMed ID: 27681343)
1. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
Borg D; Tverdovsky A; Stripp R
J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
[TBL] [Abstract][Full Text] [Related]
2. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
Scheidweiler KB; Jarvis MJ; Huestis MA
Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
[TBL] [Abstract][Full Text] [Related]
3. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
Ford LT; Berg JD
Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
[TBL] [Abstract][Full Text] [Related]
4. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
5. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
8. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
Freijo TD; Harris SE; Kala SV
J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
[TBL] [Abstract][Full Text] [Related]
9. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
10. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
11. Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.
Gundersen POM; Spigset O; Josefsson M
Drug Test Anal; 2019 Jan; 11(1):51-67. PubMed ID: 29996011
[TBL] [Abstract][Full Text] [Related]
12. Validation and application of an UPLC-MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market.
Simões SS; Silva I; Ajenjo AC; Dias MJ
Forensic Sci Int; 2014 Oct; 243():117-25. PubMed ID: 25127518
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.
Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K
Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642
[TBL] [Abstract][Full Text] [Related]
14. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
Yanes EG; Lovett DP
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
[TBL] [Abstract][Full Text] [Related]
15. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.
Adamowicz P; Zuba D; Sekuła K
Forensic Sci Int; 2013 Dec; 233(1-3):320-7. PubMed ID: 24314536
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Huestis MA
J Chromatogr A; 2014 Jan; 1327():105-17. PubMed ID: 24418231
[TBL] [Abstract][Full Text] [Related]
17. Doping control analysis of four JWH-250 metabolites in equine urine by liquid chromatography-tandem mass spectrometry.
You Y; Proctor RM; Vasilko ED; Robinson MA
Drug Test Anal; 2019 May; 11(5):649-658. PubMed ID: 30423218
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Analysis of Cannabinoid and Synthetic Cannabinoids in Dietary Supplements Using UPLC with UV and UPLC-MS-MS.
Heo S; Yoo GJ; Choi JY; Park HJ; Do JA; Cho S; Baek SY; Park SK
J Anal Toxicol; 2016 Jun; 40(5):350-9. PubMed ID: 27185817
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
